Schedule 13G ownership disclosure

Achieve Life Sciences Inc

Common Stock, par value $0.001 per share · CUSIP: 004468500

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Alyeska Investment Group, L.P.

    Shares: 4,918,822.00 · Class: 9.9%

  • Alyeska Fund GP, LLC

    Shares: 4,918,822.00 · Class: 9.9%

  • Anand Parekh

    Shares: 4,918,822.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-25-003543
Form type
SCHEDULE 13G
Filer
ACHIEVE LIFE SCIENCES, INC.
CIK
CIK 949858
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub